Cargando…
Effects of Wharton's jelly-derived mesenchymal stem cells on chronic obstructive pulmonary disease
OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is a fatal disease that shortens one's life expectancy and reduces the quality of life of patients. The current known treatments for COPD can only act to alleviate the symptoms. Recently, stem cells have demonstrated efficacy in various m...
Autores principales: | Cho, Jun Woo, Park, Ki Sung, Bae, Jin Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715889/ https://www.ncbi.nlm.nih.gov/pubmed/31489344 http://dx.doi.org/10.1016/j.reth.2019.07.009 |
Ejemplares similares
-
Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells
por: Park, Jin-Soo, et al.
Publicado: (2019) -
Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021) -
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
por: Saleh, Mahshid, et al.
Publicado: (2022) -
Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014) -
Comparative Analysis of Porcine Adipose- and Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Kim, Ga Yeon, et al.
Publicado: (2023)